Porphyrins in urine after administration of 5-aminolevulinic acid as a potential tumor marker

Photodiagnosis and Photodynamic Therapy

Volumn 8, Issue 4, 2011, Pages 328-331

  Ishizuka, Masahiro ^b   Hagiya, Yuichiro ^a   Mizokami, Yasuhiro ^a   Honda, Kanako ^a   Tabata, Kenji ^a   Kamachi, Toshiaki ^a   Takahashi, Kiwamu ^b   Abe, Fuminori ^b   Tanaka, Tohru ^b   Nakajima, Motowo ^b   Ogura, Shun ichiro ^a   Okura, Ichiro ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b SBI Pharmaceuticals Co   (Japan)

Author keywords

Aminolevulinic acid; Coproporphyrin; Tumor marker; Urine; Uroporphyrin

Indexed keywords

AMINOLEVULINIC ACID; COPROPORPHYRIN; PORPHYRIN DERIVATIVE; TUMOR MARKER; UROPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FLUID; CANCER STAGING; CONTROLLED STUDY; DRUG BLOOD LEVEL; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINALYSIS; URINE;

AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; MICE; MICE, INBRED C3H; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 84855956188     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.04.004     Document Type: Article

References (11)

1. Krammer B., Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 2008, 7:283-289.
2. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992, 14:275-292.
3. Tabata K., Ogura S., Okura I. Photodynamic efficiency of protoporphyrin IX: comparison of endogenous protoporphyrin IX induced by 5-aminolevulinic acid and exogenous porphyrin IX. Photochem Photobiol 1997, 66:842-846.
4. Smits T., Moor A.C.E. New aspects in photodynamic therapy of actinic keratoses. J Photochem Photobiol B 2009, 96:159-169.
5. Lehmann P. Methyl aminolevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007, 156:793-801.
6. Stritt A., Merk H.F., Braathen L.R., von Felbert V. Photodynamic therapy in the treatment of actinic keratosis. Photochem Photobiol 2008, 84:388-398.
7. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., Reulen H.J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7:392-401.
8. Ogura S., Ishizuka M., Mizokami Y., Honda K., Tabata K., Kamachi T., et al. Analysis of porphyrins in mouse plasma after administration of 5-aminolevulinic acid as a potential tumor marker. Porphyrins 2009, 18:25-30.
9. Hindmarsh J.T., Oliveras L., Greenway D.C. Plasma porphyrins in the porphyrias. Clin Chem 1999, 45:1070-1076.
10. Granick S., Sassa S., Granick J.L., Levere R.D., Kappas A. Assays for porphyrins, delta-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway. Proc Natl Acad Sci USA 1972, 69:2381-2385.
11. Masilamani V., Vijmasi T., Sslhi M.A., Govindaraj K., Vijaya-Raghavan A.P., Antonisamy B. Cancer detection by native fluorescence of urine. J Biomed Opt 2010, 15:057003.